Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Shares Outstanding (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Shares Outstanding for 11 consecutive years, with $3.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 803996.25% year-over-year to $3.4 million, compared with a TTM value of $3.4 million through Sep 2025, up 803996.25%, and an annual FY2024 reading of $427.0, down 99.95% over the prior year.
  • Shares Outstanding was $3.4 million for Q3 2025 at Kiora Pharmaceuticals, up from $427.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $7.1 million in Q1 2021 and bottomed at $7.0 in Q4 2021.
  • Average Shares Outstanding over 5 years is $1.1 million, with a median of $89202.5 recorded in 2021.
  • The sharpest move saw Shares Outstanding plummeted 100.0% in 2022, then skyrocketed 98724471.43% in 2023.
  • Year by year, Shares Outstanding stood at $7.0 in 2021, then changed by 0.0% to $7.0 in 2022, then skyrocketed by 12231071.43% to $856182.0 in 2023, then crashed by 99.95% to $427.0 in 2024, then skyrocketed by 803996.25% to $3.4 million in 2025.
  • Business Quant data shows Shares Outstanding for KPRX at $3.4 million in Q3 2025, $3.4 million in Q2 2025, and $427.0 in Q1 2025.